Patents Ending, Eli Lilly Chases New Drugs

The company is facing losing patent protection on drugs that accounted for 74 percent of its sales in 2009.

Topics:  drugs   
BING NEWS:
  • Eli Lilly & Co. stock underperforms Tuesday when compared to competitors
    Shares of Eli Lilly & Co. LLY sank 0.24% to $772.00 Tuesday, on what proved to be an all-around poor trading session for the stock market, with the S&P 500 Index SPX falling 0.43% to 5,881.63 and Dow ...
    12/31/2024 - 8:33 am | View Link
  • Eli Lilly & Co. stock underperforms Monday when compared to competitors
    Shares of Eli Lilly & Co. LLY slipped 1.19% to $773.84 Monday, on what proved to be an all-around poor trading session for the stock market, with the S&P 500 Index SPX falling 1.07% to 5,906.94 and ...
    12/30/2024 - 8:33 am | View Link
  • Is Eli Lilly Stock a Buy?
    Eli Lilly's stock has been a strong winner over the past few years, powered by its portfolio of glucagon-like peptide-1 (GLP-1) receptor agonist drugs. The stock is up about 36% year to date as of ...
    12/28/2024 - 8:34 pm | View Link
  • More

 

Welcome to Wopular!

Welcome to Wopular

Wopular is an online newspaper rack, giving you a summary view of the top headlines from the top news sites.

Senh Duong (Founder)
Wopular, MWB, RottenTomatoes

Subscribe to Wopular's RSS Fan Wopular on Facebook Follow Wopular on Twitter Follow Wopular on Google Plus

MoviesWithButter : Our Sister Site

More News